PGP and Miyoshi myopathy: The major concern with MDR markers is that they are weakly expressed at diagnosis but overexpressed after chemotherapy, for instance, almost 6% of newly diagnosed MM patients but more than 43% after chemotherapy (vincristine and doxorubicin) were P-gp positive [94].